Price
No data yet.
Social Signal Score
Analyst Ratings
3 analystsRevenue
$5.55M+2312.49%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- T. Ronan Kennedy
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 42
- Beta
- 2.17
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -17.50
Financials
Revenue
$5.55M+2312.5%Net Income
$-1.13MEBITDA
$-1.13MFree Cash Flow
$-460.22MEPS (diluted)
$-0.11Shares Outstanding (diluted)
10.62M+10093.2%Operating Expenses
$4.17MCash & Debt
$2.12MReturn of Capital
$120.28MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $19.19M | $-2.04M | $-1.09 |
| 2024 | $19.48M | $-3.70M | $-1.79 |
| 2023 | $24.16M | $-22.94M | $-13.32 |
| 2022 | $35.40M | $-70.08M | $-55.80 |
| 2021 | $44.48M | $-23.39M | $-19.16 |
| 2020 | $41.88M | $12.60M | $12.47 |
| 2019 | $23.65M | $-50.43M | $-114.29 |
| 2018 | $459.1K | $-412.1K | $-2.39 |
| 2017 | $4.47M | $-1.74M | $-10.44 |
| 2016 | $2.03M | $-3.36M | $-36.58 |
Valuation
YCBDhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
110+10.00%Social Signal Score
Mentions (4)
- Newsprnewswire.com·12d ago·Positive
Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation New formula combines amino acids, HMB, creatine and resveratrol as Twinlab brands await proposed acquisition by cbdMD CHARLOTTE, N.C., Sept. 24, 2026 /PRNewswire/ -- Reserveage, part of the Twinlab family of brands, announces the launch of Longev+, a new supplement available exclusively at The Vitamin Shoppe that brings muscle health and everyday performance into the healthy aging
View source ↗ - Newsprnewswire.com·34d ago·Neutral
cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness Agreement will add iconic supplement brands to cbdMD's growing multi-brand consumer wellness platform, anticipated to increase revenues to approximately $30 million. CHARLOTTE, N.C.
View source ↗ - Newsseekingalpha.com·53d ago·Positive
cbdMD, Inc. (YCBD) Q3 2026 Earnings Call Transcript cbdMD, Inc. (YCBD) Q3 2026 Earnings Call Transcript
View source ↗ - Newsprnewswire.com·56d ago·Neutral
cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results CHARLOTTE, N.C., Aug. 10, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m.
View source ↗
Earnings
Fri, Dec 18(in 2 months)
Consensus estimate $-0.09 per share
Typical surprise -18.7% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$-0.11 vs $-0.03miss
- Thu, May 14$-0.08 vs $-0.05miss
- Tue, Feb 17$-0.04 vs $-0.06beat
- Fri, Dec 19$2.78 vs $-0.07beat
- Thu, Aug 14$-0.21 vs $-0.02miss
- Thu, May 15$-1.90 vs $-1.60miss
Estimates and results for YCBD via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by YCBD officers and directors.
- Bought
- $323.1bn
- Sold
- $1.3m
7 trades
3 trades
- Crosnoe Clark R.sold
- Crosnoe Clark R.sold
- Crosnoe Clark R.sold
- Kennedy Thomas Ronanbought
- Kennedy Thomas Ronanbought
- Kennedy Thomas Ronanbought
- Kennedy Thomas Ronanbought
- Kennedy Thomas Ronanbought
90 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in YCBD.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.